1 / 6

Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]. Lipid/Lipoprotein Profile After a 6-Week Treatment with Ezetimibe (10 mg/d) and Simvastatin (40 mg/d), Simvastatin (40 mg/d) alone, Ezetimibe (10 mg/d) alone and Placebo.

blaine-ingram
Download Presentation

Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

  2. Lipid/Lipoprotein Profile After a 6-Week Treatment with Ezetimibe (10 mg/d) and Simvastatin (40 mg/d), Simvastatin (40 mg/d) alone, Ezetimibe (10 mg/d) alone and Placebo Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

  3. Kinetic parameters of ApoB-100 in VLDL, IDL, and LDL and ApoB-48 in TRL following the Placebo, Ezetimibe (10 mg) alone, Simvastatin (40 mg) alone and Ezetimibe (10 mg) plus Simvastatin (40 mg) treatment phases Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

  4. Effect of 10 mg/d of ezetimibe, 40 mg/d of simvastatin and 10 mg/d of ezetimibe plus 40 mg/d of simvastatin on markers of cholesterol synthesis and intestinal absorption Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

  5. Correlation between percentage changes in TRL apoB-48 pool size and percentage changes in TRL apoB-48 production rate following combination therapy with ezetimibe (10 mg/day) and simvastatin (40 mg/day) versus placebo Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

  6. Correlation between percentage changes in LDL apoB-100 pool size and percentage changes in LDL apoB-100 fractional catabolic rate following combination therapy with ezetimibe (10 mg/day) and simvastatin (40 mg/day) versus placebo Tremblay AJ. Et al. J Lipid Res 2009 Mar 22 [Epub ahead of print]

More Related